Vanda's Licenses CFTR Modulators From UCSF, But Not For Cystic Fibrosis

Intellectual property licensed from UCSF focuses on non-mutated, wild-type CFTR activators and inhibitors, thought to offer potential in ophthalmic, renal and gastrointestinal indications.